Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder

by Desroziers, Katia, Aballéa, Samuel, Maman, Khaled, Nazir, Jameel, Odeyemi, Isaac, Hakimi, Zalmai
Published 2013

Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated wi...

by Nazir, Jameel, Heemstra, Lars, van Engen, Anke, Hakimi, Zalmai, Ivanescu, Cristina
Published 2015

Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder

by Notte, Sherilyn M, Marshall, Thomas S, Lee, Misun, Hakimi, Zalmai, Odeyemi, Isaac, Chen, Wen-Hung, Revicki, Dennis A
Published 2012

Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom

by Aballéa, Samuel, Maman, Khaled, Thokagevistk, Katia, Nazir, Jameel, Odeyemi, Isaac A. O., Hakimi, Zalmai, Garnham, Andy, Toumi, Mondher
Published 2014